GlassScriptPhysician profile
Miranda Blevins
NPI 1891107173
$1,299.48
in general payments reported to CMS, 2019-2025
18 companies · $446 in 2025
The $446 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $11.57 · 2021: $195 · 2022: $173 · 2023: $159 · 2024: $314 · 2025: $446.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $920.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $919.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $244.66 | 2025 | Upsylon, General - Female Sui |
| Sumitomo Pharma America, INC. | $161.11 | 2023-2025 | Myfembree, Gemtesa |
| Astellas Pharma US INC | $113.07 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $109.67 | 2022-2025 | |
| Coopersurgical, INC. | $100.72 | 2021 | |
| Teleflex LLC | $93.86 | 2021 | |
| Organon LLC | $70.41 | 2024 | |
| Aspira Women'S Health INC | $58.78 | 2022 | |
| Axonics, INC. | $54.02 | 2024 | Axonics, Bulkamid |
| Myovant Sciences INC. | $48.28 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $43.78 | 2022-2025 | |
| Pfizer INC. | $42.61 | 2023-2025 | |
| Abbvie INC. | $37.71 | 2023-2024 | Lo Loestrin Fe |
| Hologic Sales and Service, LLC | $35.95 | 2023-2024 | Acessa Provu System, Coolseal Generator |
| Daiichi Sankyo INC. | $32.05 | 2023-2024 | Injectafer |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $26.93 | 2022-2025 | Slynd |
| Exact Sciences Corporation | $14.30 | 2025 | The Cologuard Plus Collection Kit |
| Lupin INC. | $11.57 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Miranda Blevins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.